Global Dermal Fillers and Botulinum Toxin Market Research Report 2022

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.
Due to the COVID-19 pandemic, the global Dermal Fillers and Botulinum Toxin market size is estimated to be worth US$ 12050 million in 2021 and is forecast to a readjusted size of US$ 30850 million by 2028 with a CAGR of 14.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Dermal Fillers and Botulinum Toxin market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Dermal Fillers and Botulinum Toxin landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.
This report focuses on Dermal Fillers and Botulinum Toxin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Dermal Fillers and Botulinum Toxin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South Korea, Middle East and Taiwan, etc.
Global Dermal Fillers and Botulinum Toxin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Dermal Fillers
Botulinum Toxin
Segment by Application
Medical
Cosmetic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong

Frequently Asked Questions